NDC 54799-508

Flurox

Fluorescein Sodium 2.5mg (0.25%), Benoxinate Hydrochloride 4mg (0.4%)

Flurox is a Ophthalmic Solution in the Human Prescription Drug category. It is labeled and distributed by Ocusoft, Inc.. The primary component is Fluorescein Sodium; Benoxinate Hydrochloride.

Product ID54799-508_5476a07b-4f5c-3b6b-38b3-b006435306c1
NDC54799-508
Product TypeHuman Prescription Drug
Proprietary NameFlurox
Generic NameFluorescein Sodium 2.5mg (0.25%), Benoxinate Hydrochloride 4mg (0.4%)
Dosage FormSolution
Route of AdministrationOPHTHALMIC
Marketing Start Date2014-01-29
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameOCuSOFT, Inc.
Substance NameFLUORESCEIN SODIUM; BENOXINATE HYDROCHLORIDE
Active Ingredient Strength3 mg/mL; mg/mL
Pharm ClassesDiagnostic Dye [EPC],Dyes [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 54799-508-05

5 mL in 1 BOTTLE, DROPPER (54799-508-05)
Marketing Start Date2014-01-29
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 54799-508-05 [54799050805]

Flurox SOLUTION
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2014-01-29
Marketing End Date2018-02-08

Drug Details

Active Ingredients

IngredientStrength
FLUORESCEIN SODIUM2.5 mg/mL

OpenFDA Data

SPL SET ID:900ec4c1-e5e3-e940-5b02-cf2589955e20
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 2099528
  • 2099132
  • Pharmacological Class

    • Diagnostic Dye [EPC]
    • Dyes [MoA]

    Trademark Results [Flurox]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    FLUROX
    FLUROX
    90051587 not registered Live/Pending
    OCuSOFT, Inc.
    2020-07-14

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.